Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study

Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study

ABSTRACT Introduction: Previous research demonstrated benefits of late conversion to mTOR inhibitors against cutaneous squamous cell carcinomas (cSCC) in kidney transplant recipients (KTR), despite of poor tolerability. This study investigated whether stepwise conversion to sirolimus monotherapy wi...

Full description

Bibliographic Details
Main Authors: Marina Rezende de Fázio, Marina Pontello Cristelli, Jane Tomimori, Carlos Eiji Koga, Marília Marufuji Ogawa, Giovanni Tani Beneventi, Helio Tedesco-Silva, José Medina-Pestana
Format: Article
Language:English
Published: Sociedade Brasileira de Nefrologia 2023-08-01
Series:Brazilian Journal of Nephrology
Subjects:
Kidney Transplant Recipients
Cutaneous Squamous Cell Carcinoma
Immunosuppression
Sirolimus
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002023005029501&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002023005029501&tlng=en

Similar Items